• 1. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 2. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

Introduction to 3-(4-fluorophenyl)phenylmethanamine (CAS No. 177976-50-0)

3-(4-fluorophenyl)phenylmethanamine, identified by its Chemical Abstracts Service (CAS) number 177976-50-0, is a significant compound in the realm of pharmaceutical chemistry and molecular biology. This compound, featuring a unique structural framework, has garnered considerable attention due to its potential applications in drug discovery and therapeutic development. The presence of a 4-fluorophenyl moiety in its structure imparts distinct chemical properties that make it a valuable candidate for further exploration.

The molecular structure of 3-(4-fluorophenyl)phenylmethanamine consists of two phenyl rings connected by a methanamine group, with one of the phenyl rings substituted with a fluorine atom. This specific arrangement not only influences its electronic properties but also enhances its reactivity, making it a versatile intermediate in synthetic chemistry. The fluorine atom introduces a degree of electronic richness, which can be exploited in various chemical transformations and biological interactions.

In recent years, the pharmaceutical industry has seen a surge in the use of fluorinated compounds due to their improved metabolic stability and enhanced binding affinity to biological targets. The incorporation of fluorine into drug molecules often leads to better pharmacokinetic profiles, making such compounds more effective and safer for therapeutic use. 3-(4-fluorophenyl)phenylmethanamine aligns with this trend, as its structural features suggest potential benefits in this regard.

One of the most promising applications of 3-(4-fluorophenyl)phenylmethanamine is in the development of novel therapeutic agents. Its unique structural motifs have been investigated for their potential in targeting various diseases, including cancer and neurological disorders. For instance, studies have shown that fluorinated aromatic compounds can exhibit potent inhibitory effects on enzymes and receptors involved in disease pathways. The 4-fluorophenyl group in 3-(4-fluorophenyl)phenylmethanamine may play a crucial role in modulating these interactions, thereby opening up new avenues for drug design.

The compound's potential as an intermediate in synthetic chemistry is also noteworthy. Its reactivity allows for the facile introduction of additional functional groups, enabling the creation of more complex molecules. This flexibility makes it an attractive building block for chemists working on drug development and material science. The ability to modify its structure further enhances its utility, as it can be tailored to meet specific requirements for different applications.

Recent research has highlighted the importance of fluorinated compounds in medicinal chemistry. Studies have demonstrated that the presence of fluorine can significantly alter the pharmacological properties of molecules, often leading to improved efficacy and reduced side effects. The work by [Author et al., Year] on fluorinated amine derivatives provides insights into how such compounds can be optimized for therapeutic use. 3-(4-fluorophenyl)phenylmethanamine fits well within this context, as its structural features are reminiscent of those found in many successful drugs.

The synthesis of 3-(4-fluorophenyl)phenylmethanamine involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions and transition-metal-mediated transformations, have been employed to achieve this goal. These methods not only enhance the efficiency of the synthesis but also allow for greater control over the structural integrity of the compound.

In conclusion, 3-(4-fluorophenyl)phenylmethanamine (CAS No. 177976-50-0) is a multifaceted compound with significant potential in pharmaceutical research and development. Its unique structural features, particularly the presence of a 4-fluorophenyl moiety, make it a valuable asset for designing novel therapeutic agents. The growing interest in fluorinated compounds underscores its importance, as these molecules continue to play a pivotal role in advancing medical science.

• 776291-03-3(4'-Fluoro-biphenyl-4-methanamine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)